BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis

Bibliographic Details
Main Authors:	Willaert, Wouter, Van Der Speeten, Kurt, Liberale, Gabriel, Ceelen, Wim
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682259/

Similar Items

A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion
by: Haslinger, Michelle, et al.
Published: (2013)

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
by: Huang, Yeqian, et al.
Published: (2015)

Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion
by: Nair, Rajalakshmi L, et al.
Published: (2006)

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations
by: Pelz, Joerg OW, et al.
Published: (2006)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Piso, Pompiliu, et al.
Published: (2004)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
by: Bielen, Rob, et al.
Published: (2013)

Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Benizri, Emmanuel I, et al.
Published: (2012)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study
by: Tang, Li, et al.
Published: (2011)

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Rodt, Anne Peen, et al.
Published: (2013)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
by: Aras Emre Canda, et al.
Published: (2018-03-01)

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
by: Vassos, Nikolaos, et al.
Published: (2016)

Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
by: Spiliotis, J. D., et al.
Published: (2014)

Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
by: Cardi, Maurizio, et al.
Published: (2015)

Progression of peritoneal adenomucinosis to the scrotum: a rare occurrence treated with cytoreductive surgery and hyperthermic chemoperfusion of the scrotum in two patients.
by: Sardi, Armando, et al.
Published: (2014)

Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival
by: Bijelic, Lana, et al.
Published: (2012)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Murughan, Kavita, et al.
Published: (2014)

Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
by: Lemoine, Lieselotte, et al.
Published: (2016)

Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats
by: Otto, Jens, et al.
Published: (2007)

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
by: Kondo, A., et al.
Published: (1996)

The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis
by: FRANCESCUTTI, VALERIE, et al.
Published: (2013)

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
by: Casado-Adam, Angela, et al.
Published: (2011)

Hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin: Influence of perfusion temperature on postoperative outcome and survival
by: Verhulst, Johanna
Published: (2015)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies
by: Wu, Hai-Tao, et al.
Published: (2016)

Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea
by: Jo, Min Hyeong, et al.
Published: (2016)

Erratum to comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy
Published: (2016)

Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy
by: Leone, Andrew, et al.
Published: (2016)

Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)
by: Cooksley, Timothy J, et al.
Published: (2011)

ICU outcome of patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a single-center study
by: Nadeem, A, et al.
Published: (2015)

Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience
by: Kajdi, Marie-Elisabeth, et al.
Published: (2014)

Organ dysfunction in critically ill cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
by: ÑAMENDYS-SILVA, SILVIO A., et al.
Published: (2015)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
by: Campanati, Renato Gomes, et al.
Published: (2014)

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
by: Barbosa, Luiza Damian Ribeiro, et al.
Published: (2016)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
by: Bjersand, Kathrine, et al.
Published: (2015)

Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Macrì, Antonio, et al.
Published: (2015)

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial
by: Giessen, Clemens, et al.
Published: (2011)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Girshally, Ramy, et al.
Published: (2016)

Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
by: Gremonprez, Félix, et al.
Published: (2015)

Equine Torovirus (BEV) Induces Caspase-Mediated Apoptosis in Infected Cells
by: Maestre, Ana M., et al.
Published: (2011)

BirdsEyeView (BEV): graphical overviews of experimental data
by: Zhang, Lifeng, et al.
Published: (2012)

Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients
by: Preti, Vinicius, et al.
Published: (2012)